Author(s):
Sabreena S Sheikh, Anwar H Ansari, Manoj K Mudigubba, Saurabh Dahiya
Email(s):
saurabhdahiya@gmail.com
DOI:
10.5958/0974-360X.2020.00671.X 
Address:
Sabreena S Sheikh1, Anwar H Ansari2, Manoj K Mudigubba3, Saurabh Dahiya4
1Department of Pharmacy, Lingayas University, Faridabad, Haryana-121002, India.
2Department of Cardiology, Safdarjung Hospital, Ansari Nagar, New Delhi-110029, India.
3Department of Pharmacy, M.S Ramaiah University of Applied Sciences, Banglore-560054, India.
4Department of Pharmaceutical Chemistry, DIPSAR, Delhi Pharmaceutical Sciences and Research University, New Delhi-110017, India.
*Corresponding Author
Published In:
Volume - 13,
Issue - 8,
Year - 2020
ABSTRACT:
Rheumatic heart disease (RHD) is an inflammatory disease of the heart, and it has major cause of morbidity and mortality in developing countries. It has significant impact on the quality of life of RHD patients. Objective: To assess the Quality of life in patients with chronic Rheumatic heart disease. Materials and methods: This prospective observational study was conducted at the Safdarjung Hospital, New Delhi for a period of 18 months. Study subjects are the patients who were diagnosed with chronic rheumatic heart disease at the outpatient department. A total of 500 subjects suffering from RHD and 100 Controls without RHD were identified during the study period. SF-36 health survey questionnaire was used to interview the subjects. The scores of health survey questionnaire was analysed descriptively and ANOVA is used to find out the significant differences. SPSS version-20 was used for data analysis. Results: Out of 600 subjects, 500 were the cases and 100 were the controls. 54.4% were males and 45.8% were females. Majority of the cases were belonged to the age group 36-40 years (19%) with the mean age group 35.7±9.2 years. 80% of the subjects were identified with moderate rheumatic heart disease and 20% were severe. Physical functioning, role of limitations due to physical health and emotional problems, social functioning and health change has shown the significant difference. Conclusion: It was seen that most of the domains of SF-36 were significant from which we can conclude that there is the relation between RHD and quality of life. Considering the poor quality of life in rheumatic heart disease patients, multimodal approach (psychiatric consultation, enrolment in mental support group, and occupational help) to provide overall care to a rheumatic heart disease patient should be considered.
Cite this article:
Sabreena S Sheikh, Anwar H Ansari, Manoj K Mudigubba, Saurabh Dahiya. To assess the quality of Life in patients with Chronic Rheumatic Heart Disease. Research J. Pharm. and Tech. 2020; 13(8):3792-3796. doi: 10.5958/0974-360X.2020.00671.X
Cite(Electronic):
Sabreena S Sheikh, Anwar H Ansari, Manoj K Mudigubba, Saurabh Dahiya. To assess the quality of Life in patients with Chronic Rheumatic Heart Disease. Research J. Pharm. and Tech. 2020; 13(8):3792-3796. doi: 10.5958/0974-360X.2020.00671.X Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-8-44
REFERENCES:
1. Reményi B, Wilson N, Steer A, Ferreira B, Kado J, Kumar K, et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline. Nat Rev Cardiol.2012Feb 28;9(5):297-309.
2. Gartlan WA, Reti K. Benzathine Penicillin. In: Stat Pearls. Treasure Island (FL): Stat Pearls Publishing; 2019 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507723/
3. WHO Model Prescribing Information: Drugs Used in the Treatment of Streptococcal Pharyngitis and Prevention of Rheumatic Fever. https://apps.who.int/medicinedocs/en/d/Js2252e/3.2.2.html. Last accessed 29 Jul 2019
4. Pilgrim T, Kalesan B, Karki P, et al. Protocol for a population-based study of rheumatic heart disease prevalence and cardiovascular outcomes among schoolchildren in Nepal. BMJ Open 2012;2: pii: e001320
5. S. Ramakrishna, Shyam S. Kothari.et al. Prevalence of rheumatic heart disease: Has it declined in India? The National Medical Journal of India. 2009; 22:72-74
6. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5: 685-94.
7. Perloff JK. Congenital heart disease in adults. A new cardiovascular subspecialty. Circulation 1991; 84:1881–1890.
8. Remenyi B, Carapetis J, Wyber R, Taubert K, Mayosi BM; World Heart Federation. Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease. Nat Rev Cardiol. 2013 May;10: 284-92.
9. Carapetis JR, Beaton A, Cunningham MW, Guilherme L, Karthikeyan G, Mayosi BM, et al. Acute Rhuematic fever and Rheumatic Heart disease. Nat Rev Dis Primers. 2016;2: 15084.
10. Idorn L, Jensen AS, Juul K, Overgaard D, Nielsen NP, Sørensen K, Reimers JI, Søndergaard L. Quality of life and cognitive function in Fontan patients, a population-based study. Int J Cardiol. 2013;168: 3230-5
11. Christine Bocéréan and Emilie Dupret. A validation study of the Hospital Anxiety and Depression Scale (HADS) in a large sample of French employees. BMC Psychiatr. 2014;14: 354.
12. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results. Journal of Psychosomatic Research: 1997;42: 17-41
13. Kumar RK, Tandon R. Rheumatic fever & rheumatic heart disease: the last 50 years. Indian J Med Res. 2013;137:643-58.
14. Riaz A, Hanif MI, Khan IH, Hanif A, Mughal S, Anwer A. Quality of life in patients with rheumatic heart disease. J Pak Med Assoc. 2018;68:370-375.
15. Ormel J, Von Korff M, Burger H, Scott K, Demyttenaere K, Huang YQ, et al. Mental disorders among persons with heart disease – results from World Mental Health surveys. Gen Hosp Psychiatr. 2007;29:325-34.
16. DeJean D, Giacomini M, Vanstone M, Brundisini F. Patient experiences of depression and anxiety with chronic disease: a systematic review and qualitative meta-synthesis. Ont Health Technol Assess Ser. 2013;13:1-33.
17. Guyatt GH. Measurement of health-related quality of life in heart failure. J Am Coll Cardiol. 1993;22: A185-A91.
18 De Maso DR, Lauretti A, Spieth L, Van Der Feen JR, Jay KS, Gauvreau K, et al. Psychosocial factors and quality of life in children and adolescents with implantable cardioverter defibrillators. Am J Cardiol. 2004; 93:582-7.
19. Ruo B, Rumsfeld JS, Hlatky MA, Liu H, Browner WS, Whooley MA, et al. Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA. 2003; 290:215-21.
20. Lane D, Lip G, Millane T. Quality of life in adults with congenital heart disease. Heart. 2002; 88:71-5.
21. Varni JW, Limbers CA, Burwinkle TM. Impaired health-related quality of life in children and adolescents with chronic conditions: a comparative analysis of 10 disease clusters and 33 disease categories/severities utilizing the Peds QL™ 4.0 Generic Core Scales. Health Qual Life Outcomes. 2007; 5:12-43.
22. Khalil A, Mansour M, Attaia H. Effect of Chronic Rheumatic Heart Disease on Intellectual Functioning in School Age Children. Curr Pshyciatry. 1998; 5:65-8.
23. Varni JW, Burwinkle TM, Lane MM. Health-related quality of life measurement in pediatric clinical practice: an appraisal and precept for future research and application. Health Qual Life Outcomes. 2005; 3:32-4.
24. Herring MP, Puetz TW, O'Connor PJ, Dishman RK. Effect of exercise training on depressive symptoms among patients with a chronic illness: a systematic review and meta-analysis of randomized controlled trials. Arch Intern Med. 2012; 172:101-11.